Metabolomics platform delivering biological insights from biochemical analysis
Metabolon operates a Precision Metabolomics platform that maps the complete chemical composition of biological samples using LC-MS instrumentation and a library of 5,200+ known molecular compounds. The company is actively scaling chemical inventory and automating data curation pipelines—indicating an operational shift toward higher throughput and standardization. Sales hiring outpaces research and engineering combined, suggesting a push to commercialize existing platform capabilities rather than build new technology.
Metabolon provides metabolomics analysis services to life sciences researchers and pharmaceutical companies developing and testing drugs. The platform delivers a detailed biochemical profile of a single biological sample, revealing metabolite-level changes caused by disease, treatment, diet, or environmental factors. The company serves academia, clinical trial programs, population health research, and consumer product development. Founded in 2000 and based in Morrisville, North Carolina, Metabolon operates a proprietary library of molecular compounds and employs experienced metabolomics scientists to interpret results and identify biomarkers and novel therapeutic opportunities.
Metabolon operates a Precision Metabolomics platform that analyzes biological samples using LC-MS instrumentation to measure metabolite levels. The platform includes a library of 5,200+ known molecular compounds and provides a comprehensive biochemical profile of physiology at a single point in time.
Metabolon uses LC-MS for analytical instrumentation, Salesforce and Marketo for sales operations, AWS and VMware for infrastructure, LIMS for lab management, Python and Terraform for automation, and Google Analytics and Looker Studio for business analytics.
Other companies in the same industry, closest in size